NBIX
Neurocrine Biosciences Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 5/10
- Momentum↓ 4/10
NBIX Growth
- Revenue Y/Y↑ 21.45%
- EPS Y/Y↑ 41.47%
- FCF Y/Y↑ 34.37%
NBIX Profitability
- Gross margin ↑ 98.20%
- EPS margin↑ 16.70%
- ROIC↑ 20.00%
NBIX Risk
- Debt / Equity↓ 0.1
- Debt / FCF↓ 0.0
- Interest coverage↓ NA
Neurocrine Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.